AI in Outpatient Practice for Diagnosing Aortic Stenosis and Diastolic Dysfunction

Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age60+
SponsorMayo Clinic

About this trial

Two recently developed artificial intelligence-enabled electrocardiogram (AI-ECG) models have been developed to detect aortic stenosis (AS) and diastolic dysfunction (DD). AI-ECG for AS has a sensitivity of 78% and specificity of 74%, and AI-ECG for DD has a sensitivity of 83% and specificity of 80%. However, these models have never been prospectively applied to diagnose AS or DD, which may be useful for patients and providers from a diagnostic and prognostic perspective and especially in settings where access to higher- level medical care is limited. In this study, we aim to determine the clinical utility of these AI-ECG models by prospectively applying them to an outpatient cohort and then completing a focused point-of-care ultrasound to evaluate those who are AI-ECG positive for AS and DD.

Eligibility criteria

Qualifiers

≥ 60 years of age must have a clinical scheduled ECG performed.

Disqualifiers

< 59 years of age

Is not scheduled for a clinical ECG

Unable to provide consent.

Trial design

Treatments tested in this trial

  • AI-ECG Dashboard
  • Point of care ultrasound (POCUS)

Treatment groups

2,000 Participants
are divided into 1 treatment group

Sponsors and collaborators